| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8733804 | Current Problems in Cancer | 2018 | 11 Pages |
Abstract
Clinical and pathological diagnosis of retroperitoneal FDCS needs vigilance. Both lymphoma and sarcoma chemotherapy regimens are effective. Due to this pathology's rareness we highlighted a lack of treatment consensus and proposed options.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Rym Bouriga, Nihed Abdessaied, Makram Hochlef, Najoua Mallat, Mohamed Mahjoub, Badereddine Sriha, Slim Ben Ahmed,